1. Terzi'c, J.; Grivennikov, S.; Karin, E.; Karin, M. Inflammation and colon cancer. Gastroenterology 2010, 138, 2101-2114
2. Johns, L.E.; Houlston, R.S. A systematic review and meta-analysis of familial colorectal cancer risk. Am. J. Gastroenterol. 2001, 96, 2992-3003.
3. Tenesa, A.; Dunlop, M.G. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat. Rev. Genet. 2009, 10, 353-358.
4. Huxley, R.R.; Ansary-Moghaddam, A.; Clifton, P.; Czernichow, S.; Parr, C.L.;Woodward, M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: A quantitative overview of the epidemiological evidence. Int. J. Cancer 2009, 125, 171-180.
5. Watson, A.J.M.; Collins, P.D. Colon cancer: A civilization disorder. Dig. Dis. 2011, 29, 222-228.
6. Meyerhardt, J.A.; Catalano, P.J.; Haller, D.G.; Mayer, R.J.; Macdonald, J.S.; Benson, A.B.; Fuchs, C.S. Impact of diabetes mellitus on outcomes in patients with colon cancer. J. Clin. Oncol. 2003, 21, 433-440.
7. Hjartaker A. et al. Subsite-specific dietary risk factors for colorectal cancer: a review of cohort studies. J Oncol 2013, Article ID 703854, 14 pages (2013).
8. Theodoratou E. et al. Associations between dietary and lifestyle risk factors and colorectal cancer in the Scottish population. Eur J Cancer Prev 23, 8-17 (2014).
9. Rasool S., Kadla S. A., Rasool V. & Ganai B. A. A comparative overview of general risk factors associated with the incidence of colorectal cancer. Tumor Biol 34, 2469-2476 (2013).
10. Esposito K. et al. Colorectal cancer association with metabolic syndrome and its components: A systematic review with meta-analysis. Endocrine 44, 634-647 (2013).
11. Larsson S. C., Orsini N. & Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97, 1679-1687 (2005)
12. Raskov H., Pommergaard H. C., Burcharth J. & Rosenberg J. Colorectal carcinogenesis-update and perspectives. World J Gastroentero 20, 18151-18164 (2014)
13. Donohoe C, O’farrell N, Doyle S, Reynolds J (2014). The role of obesity in gastrointestinal cancer: evidence and opinion. Therap Adv Gastroenterol, 7, 38-50.
14. Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2014 г.//Издательская группа РОНЦ. 2016. - 217 С.
15. Finan PJ, Ritchie JK, Hawley PR. Synchronous and 'early' metachronous carcinomas of the colon and rectum. Br J Surg 1987; 74:945-47.
16. Barillari P, Ramacciato G, De Angelis R et al. Effect of preoperative colonoscopy on the incidence of synchronous and metachronous neoplasms, Acta Chir Scand 1990; 156: 163-166
17. Computed tomographic colonography compared with colonoscopy or barium enema for diagnosis of colorectal cancer in older symptomatic patients: two multicentre randomised trials with economic evaluation (the SIGGAR trials). Health Technol Assess. 2015 Jul;19(54):1-134.
18. Starck M, Bohe M, Simanaitis M, Valentin L. Rectal endosonography can distinguish benign rectal lesions from invasive early rectal cancers. Colorectal Dis. 2003 May; (3):246-50.
19. Niekel MC, Bipat S, Stoker J, et al. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology. 2010 Dec; 257(3):674-84.
20. Lee EJ, Lee JB, Lee SH, et al. Endoscopic submucosal dissection for colorectal tumors--1,000 colorectal ESD cases: one specialized institute's experiences. Surg Endosc. 2013 Jan; 27(1):31-9.
21. Федянин М.Ю., Трякин А.А., Тюляндин С.А. Адъювантная химиотерапия рака толстой кишки. // Фарматека №7(220) 2011, с.21-27.
22. Hughes KS, Simon R, Songhorabodi S , et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery. 1986 Aug; 100(2):278-84.
23. Oshowo A, Gillams A, Harrison E, et al. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg. 2003 Oct; 90(10):1240-3
24. Falcone A., Cremolini C., Masi G., et al. FOLFOXIRI/bevacizumab (bev) versus FOLFIRI/bev as first-line treatment in unresectable metastatic colorectal cancer (mCRC) patients (pts): Results of the phase III TRIBE trial by GONO group. J Clin Oncol. 31, 2013 (suppl; abstr 3505).
25. Федянин М.Ю., Трякин А.А., Тюляндин С.А. Потенциальные предикторы эффективности aHTu-EGFR-терапии при метастатическом раке толстой кишки. // Онкологическая колопроктология 2013, №2, стр.21-30.
26. Landmann RG, Weiser MR. Clin Colon Rectal Surg. 2005 Aug;18(3):182-9. Surgical management of locally advanced and locally recurrent colon cancer.
27. Guenaga KF, Matos D, Wille-J0rgensen P. Cochrane Database Syst Rev. 2011 Sep 7; (9):CD001544. Epub 2011 Sep 7)
28. van der Pas M. H. G. M. et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial //The lancet oncology. -2013. - Т. 14. - №. 3. - С. 210-218.
29. Kang S. B. et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial //The lancet oncology. - 2010. - Т. 11. - №. 7. - С. 637-645.
30. Jeong S. Y. et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an openlabel, non-inferiority, randomised controlled trial //The Lancet Oncology. - 2014. - Т. 15. - №. 7. - С. 767-774.
31. Green B. L. et al. Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer //British Journal of Surgery. - 2013. - Т. 100. - №. 1. - С. 75-82.
32. De Salvo GL, Gava C, Lise M et al. Curative surgery for obstruction from primary left colorectal carcinoma: Primary or staged resection. The Cochrane Database of Systematic Reviews 2006 Issue 2